
Blumika 500mg Injection
Marketer
Blue Cross Laboratories Ltd
Salt Composition
Amikacin (500mg)
Overview Blumika 500mg Injection
Cefixime 500mg Injection combats bacterial infections affecting various body parts, such as the urinary tract, musculoskeletal system, respiratory system (pneumonia), central nervous system, and bloodstream. This antibiotic is also prophylactically administered to hospitalized individuals to avert infections. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously or intramuscularly by a healthcare provider, this injection requires regular, evenly spaced doses as directed. Complete the prescribed course, even with symptom improvement, to prevent relapse. Common side effects include injection site irritation and elevated blood urea nitrogen. Persistent side effects or lack of improvement warrant medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity; thus, strict adherence to the physician's instructions is crucial, including regular monitoring of kidney function, hearing, and urine analysis. This medication is contraindicated during pregnancy and breastfeeding; inform your doctor of your pregnancy status or breastfeeding plans.
Primary Ingredients of Blumika 500mg Injection
No text provided to rephrase.
Uses of Blumika 500mg Injection
Infections caused by bacteria
Major Benefits of Blumika 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Blumika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Blumika 500mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Blumika 500mg Injection works:
The antibiotic injection Blumika 500mg inhibits bacterial proliferation by disrupting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Blumika 500mg Injection does not interact negatively with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Blumika 500mg Injection during pregnancy carries a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks, necessitating prescription. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility studies indicate Blumika 500mg Injection poses minimal risk to breastfeeding infants. Research in humans shows negligible transfer of the medication into breast milk, suggesting no harm to the nursing child.
DrivingUNSAFE
The administration of Blumika 500mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Blumika 500mg Injection requires careful consideration. A modified dosage of Blumika 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Blumika 500mg Injection in individuals with liver conditions is likely safe. Existing evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Blumika 500mg Injection :
Omitting a scheduled dose of Blumika 500mg Injection warrants immediate physician consultation.
Facts to Know About Blumika 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
